Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab

Activity: Talk or presentationTalk or presentation at a workshop/seminar

Description

Oral presentation
Period19 Oct 2018
Event titleORC day 2018
Event typeConference
LocationJette, Belgium
Degree of RecognitionLocal